Pioneers in early and reliable Alzheimer's disease diagnostics

Cerebrospinal fluid (CSF) biomarkers, developed first by Fujirebio more than 25 years ago, have evolved over time from research biomarkers to specialized diagnostic testing, and from usage by early adopters to a widespread implementation as routine testing today.

Diagnosis based on CSF samples allows the detection of four proteins; two forms of amyloid (Aβ1-42 and Aβ1-40) proteins and two forms of Tau (Total Tau and phospho-Tau) proteins. If a patient has Alzheimer’s disease, then these proteins will be present in abnormally low (Aβ1-42 and Aβ1-42/Aβ1-40 ratio) and high (Total Tau and phospho-Tau) levels. The Aβ1-42 protein levels will even be low before the symptoms of the disease start to show.

As pioneers in the field of early and reliable Alzheimer's disease diagnostics Fujirebio has been there every step of the way. This page collects resources about how we contribute and collaborate closely with the international clinical community and partner organizations to develop the neurodegeneration diagnostic tools of the future.

 
Don't miss our series of webinars

Are you a healthcare professional working with Alzheimer’s disease research or patient management? Our webinar series is for you.

It features leading experts addressing the most current topics in Alzheimer's disease diagnostics, from automated CSF-based biomarkers in routine use, through the perspectives of automated plasma/blood-based biomarker testing and to the possible applications for completely novel CSF biomarkers.

Sign up for the next live webinar or watch the replays of the latest webinars here.

 

 

1. World Alzheimer Report 2015

 
Read more about our engagement in advancing Alzheimer's disease testing below
 or contact us today
 

Insights

Read about our automated CSF testing solutions

Download our Lumipulse G Neuro panel product leaflet to learn about the possibilities for automated CSF biomarker testing.

Download leaflet

Read about our automated CSF testing solutions

Download our Lumipulse G Neuro panel product leaflet to learn about the possibilities for automated CSF biomarker testing.

Download leaflet